Clinical Trials Browser

Phase 2 × talabostat × Clear all

NCT00086203 2015-03-25

Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00080080 2007-06-08

Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

Lung Neoplasms

NCT00083239 2007-06-08

Study of Talabostat in Advanced Melanoma

Phase 2 Completed

Melanoma, Skin Neoplasms